021-51111890
购物车（）
sales@molnova.cn
XRK3F2
CAS No. ——
XRK3F2 ( —— )
产品货号. M16928 CAS No. ——
XRK3F2 is a specific ZZ-domain of ubiquitin-binding protein p62 (Sequestosome 1) inhibitor that inhibits MM cell growth and BMSC growth enhancement of human MM cells.
纯度: 99.03% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称XRK3F2
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述XRK3F2 is a specific ZZ-domain of ubiquitin-binding protein p62 (Sequestosome 1) inhibitor that inhibits MM cell growth and BMSC growth enhancement of human MM cells.
-
产品描述XRK3F2 is a specific ZZ-domain of ubiquitin-binding protein p62 (Sequestosome 1) inhibitor that inhibits MM cell growth and BMSC growth enhancement of human MM cells; inhibits TNFα-induced osteoclast formation, and has IC50 of 4.35 uM 5TGM1 cells and 4.6 uM for the human MM1.S cell line; induces new cortical bone formation in MMBD in vivo, and alters MM cell-BMSC cell interactions by reducing MM cell-derived TNFα in the myeloma microenvironment.
-
同义词——
-
通路Autophagy
-
靶点Autophagy
-
受体Autophagy
-
研究领域——
-
适应症——
化学信息
-
CAS Number——
-
分子量435.90
-
分子式C23H24ClF2NO3
-
纯度99.03% (HPLC)
-
溶解度——
-
SMILESCN(CCO)C1=CC=C(OCC2=CC=C(F)C=C2)C(OCC3=CC=C(F)C=C3)=C1.[H]Cl
-
化学全称2-((3,4-bis((4-fluorobenzyl)oxy)benzyl)amino)ethan-1-ol hydrochloride
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Teramachi J, et al. Leukemia. 2016 Feb;30(2):390-8.
2.Adamik J, et al. Front Endocrinol (Lausanne). 2018 Jun 29;9:344.
2.Adamik J, et al. Front Endocrinol (Lausanne). 2018 Jun 29;9:344.
产品手册
关联产品
-
BRD5631
A small-molecule enhancer of autophagy through an mTOR-independent pathway; significantly reduces the number of eGFP-HDQ74-positive cells, and increases the transcript level of p62 in Atg5+/+ MEFs.
-
Sulfadiazine
Sulfadiazine is a sulfonamide antibiotic. It eliminates bacteria that cause infections by stopping the production of folic acid inside the bacterial cell, and is commonly used to treat urinary tract infections (UTIs).
-
LY2183240
LY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM). LY2183240 is a novel and highly effective blocker of anandamide uptake (IC50 = 270 pM).
